begin privacyenhanced message proctype micclear originatorname webmasterwwwsecgov originatorkeyasymmetric mfgwcgyevqgbaqicafdsgawrwjawsnkkavtbzyzmragjlwykxmzvdtinen twsmvrzladbmyqaionwgsdwpoamdtdezxmmztbtwidaqab micinfo rsamdrsa ajuftbhimiulkocetrunvxfmsnqdunnbnhwikbjqewcxgntmjxrgmg bzoorbtwgtlmcunoqg txt 20100401 hdrsgml 20100401 20100401144515 accession number 000095012310031390 conformed submission type da public document count filed date 20100401 date change 20100401 subject company company data company conformed name global med technology inc central index key 0001009463 standard industrial classification servicesprepackaged software 7372 irs number 841116894 state incorporation fiscal year end 1231 filing value form type da sec act 1934 act sec file number 00554591 film number 10723447 business address street 12600 colfax street suite c city lakewood state zip 80215 business phone 3032382000 mail address street 12600 west colfax avenue street suite c city lakewood state zip 801253737 former company former conformed name global data technology inc date name change 19960808 filed by company data company conformed name global med technology inc central index key 0001009463 standard industrial classification servicesprepackaged software 7372 irs number 841116894 state incorporation fiscal year end 1231 filing value form type da business address street 12600 colfax street suite c city lakewood state zip 80215 business phone 3032382000 mail address street 12600 west colfax avenue street suite c city lakewood state zip 801253737 former company former conformed name global data technology inc date name change 19960808 da gscdzahtm da scdza united state security exchange commission washington dc 20549 schedule d solicitationrecommendation statement section d security exchange act 1934 amendment no global med technology inc name subject company global med technology inc name person filing statement common stock par value 001 per share series convertible preferred stock par value 001 per share title class security e cusip number class security michael ruxin md chief executive officer global med technology inc 12600 west colfax suite c lakewood 80215 303 2382000 name address telephone number person authorized receive notice communication behalf person filing statement copy to clayton parker martin schrier kl gate llp 200 biscayne boulevard suite 3900 miami florida 33131 305 5393300 check box filing relates solely preliminary communication made commencement tender offer amendment no solicitationrecommendation statement schedule d amends supplement solicitationrecommendation statement schedule d filed global med technology inc colorado corporation global med security exchange commission the sec march 2010 a amended supplemented time time schedule d schedule d relates offer haemonetics corporation massachusetts corporation haemonetics wholly owned subsidiary atlas acquisition corp colorado corporation purchaser purchase outstanding share global meds common stock 001 par value per share the global med common stock outstanding share global meds series convertible preferred stock 001 par value per share the global med preferred stock upon term subject condition set forth haemonetics offer purchase dated february 19 2010 a amended supplemented time time offer purchase offer purchase attached exhibit aa schedule filed haemonetics sec february 19 2010 a amended supplemented time time schedule to term offer a defined below set forth offer purchase related letter transmittal global med common stock letter transmittal global med preferred stock each context requires letter transmittal together offer purchase offer capitalized term used otherwise defined herein shall respective meaning ascribed term schedule d item schedule d hereby amended supplemented adding following immediately subheading entitled forward looking statements m expiration subsequent offering period exercise topup option 1200 midnight boston massachusetts time march 31 2010 subsequent offering period expired extended marking conclusion offer based information provided computershare trust company na haemonetics expiration subsequent offering period 3960 share global med preferred stock approximately 34398052 share global med common stock tendered withdrawn offer including share tendered subsequent offering period tendered share constituted 100 share global med preferred stock outstanding approximately 897 share global med common stock outstanding purchaser accepted payment share validly tendered pursuant term merger agreement purchaser exercised topup option increase ownership global med common stock least one share 90 number share global med common stock outstanding after giving effect issuance share global med common stock pursuant topup option described merger agreement purchase price per share global med common stock sold purchaser connection exercise topup option equal common stock offer price the topup option purchase price aggregate topup option purchase price paid purchaser secured promissory note principal amount equal topup option purchase price multiplied number topup option share haemonetics advised global med intends complete acquisition global med merging purchaser global med way short form merger without vote meeting shareholder global med accordance applicable provision colorado law merger remaining publiclyheld share global med common stock other share global med common stock dissenters right validly exercised perfected applicable colorado law converted right receive 122 per share global med common stock net holder cash without interest le applicable withholding tax representing price paid offer colorado law haemonetics required give ten days prior notice merger remaining shareholder global med haemonetics informed global med expects complete merger promptly thereafter following merger global med become whollyowned subsidiary haemonetics share global med common stock longer eligible quotation otc bulletin board april 2010 haemonetics purchaser issued press release announcing conclusion offer full text press release issued haemonetics purchaser set forth exhibit a hereto incorporated herein reference item schedule d hereby amended supplemented changing subheading entitled m forwardlooking statements reflect following n forwardlooking statements item schedule d hereby amended supplemented adding following a press release issued haemonetics purchaser dated april 2010 incorporated reference exhibit ad amendment no schedule to signature due inquiry best knowledge belief certify information set forth statement true complete correct global med technology inc by s michael ruxin md name michael ruxin md title chief executive officer dated april 2010 end privacyenhanced message